The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Open accessAbstract
Mutations of the tricarboxylic acid cycle enzyme fumarate hydratase cause hereditary leiomyomatosis and renal cell cancer. Fumarate hydratase-deficient renal cancers are highly aggressive and metastasize even when small, leading to a very poor clinical outcome. Fumarate, a small molecule metabolite that accumulates in fumarate hydratase-deficient cells, plays a key role in cell transformation, making it a bona fide oncometabolite. Fumarate has been shown to inhibit α-ketoglutarate-dependent dioxygenases that are involved in DNA and histone demethylation. However, the link between fumarate accumulation, epigenetic changes, and tumorigenesis is unclear. Here we show that loss of fumarate hydratase and the subsequent accumulation of fumarate in mouse and human cells elicits an epithelial-to-mesenchymal-transition (EMT), a phenotypic switch associated with cancer initiation, invasion, and metastasis. We demonstrate that fumarate inhibits Tet-mediated demethylation of a regulatory region of the antimetastatic miRNA cluster mir-200ba429, leading to the expression of EMT-related transcription factors and enhanced migratory properties. These epigenetic and phenotypic changes are recapitulated by the incubation of fumarate hydratase-proficient cells with cell-permeable fumarate. Loss of fumarate hydratase is associated with suppression of miR-200 and the EMT signature in renal cancer and is associated with poor clinical outcome. These results imply that loss of fumarate hydratase and fumarate accumulation contribute to the aggressive features of fumarate hydratase-deficient tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, fumarate inhibits TET enzymes, which stimulate EMT, leading to cancer metastasis131,132.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]
In the citing paper
“Further confirmation of fumarate as an oncometabolite was verified by experimental data showing that tumor cells lost their ability to invade and migrate when the function of fumarate hydratase was restored by an external expression vector131.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [131]
In the citing paper
“In recent years, two landmark genomic studies carried out in human glioma and acute myeloid leukaemia (AML) found mutations in IDH1/2 and it is now appreciated that these enzymes (which drive elevated production of D-2-HG) are the most frequently mutated metabolic genes in human cancer112-114.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
MethPrimer: designing primers for methylation PCRs
Li, L.-C., & Dahiya, R. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.11.1427 · Cited by 2,741
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
The Cancer Genome Atlas Research Network (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505917 · Cited by 1,336
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 585
Oxidative stress and metabolism meet epigenetic modulation in physical exercise
García‐Giménez, J. L., Cánovas‐Cervera, I., & Pallardó, F. V. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.01.008 · Cited by 50
T cell-based cancer immunotherapy: opportunities and challenges
Ma, K., Xu, Y., Cheng, H., Tang, K., Ma, J., & Huang, B. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.03.054 · Cited by 47
Analyzing Tumor Metabolism In Vivo
Faubert, B., & DeBerardinis, R. J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121954 · Cited by 44
Metabolism and Transcription in Cancer: Merging Two Classic Tales
Martín-Martín, N., Carracedo, A., & Torrano, V. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00119 · Cited by 43
Carter, C. S., Skala, S. L., Chinnaiyan, A. M., McHugh, J. B., Siddiqui, J., Cao, X., Dhanasekaran, S. M., Fullen, D. R., Lagstein, A., Chan, M. P., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000840 · Cited by 44
Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis
Sharma, S., Agnihotri, N., & Kumar, S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114943 · Cited by 42
Bailey, P. S. J., & Nathan, J. A. (2018) · Biomedicines · doi:10.3390/biomedicines6020060 · Cited by 41
Ji, L., Fan, X., Zhou, F., Gu, J., & Deng, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29256 · Cited by 41
Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease
Huang, M., Lou, D. W., Charli, A., Kong, D., Jin, H., Zenitsky, G. D., Anantharam, V., Kanthasamy, A., Wang, Z., & Kanthasamy, A. G. (2021) · JCI Insight · doi:10.1172/jci.insight.138088 · Cited by 45
Johnson, T. I., Costa, A. S. H., Ferguson, A. N., & Frezza, C. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0912-3 · Cited by 40
Self-citationJiang, T., Rivera, F. J. S., Soto‐Feliciano, Y. M., Yang, Q., Song, C., Bhuatkar, A., Haynes, C. M., Hemann, M. T., & Xue, W. (2020) · Hepatology · doi:10.1002/hep.31685 · Cited by 40
Sharma, N. K., & Pal, J. K. (2020) · Current Molecular Medicine · doi:10.2174/1566524020666200521075252 · Cited by 40
Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
The contribution of mitochondrial DNA alterations to aging, cancer, and neurodegeneration
Picca, A., Guerra, F., Calvani, R., Coelho‐Júnior, H. J., Leeuwenburgh, C., Bucci, C., & Marzetti, E. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112203 · Cited by 43
Verma, A., & Lindroth, A. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01537-7 · Cited by 47
Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer
Bhattacharya, D., & Scimè, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00773 · Cited by 39
Metabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C. D., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 39
Zheng, L., Zhu, Z.-R., Sneh, T., Zhang, W.-T., Wang, Z.-Y., Wu, G., He, W., Qi, H., Wang, H., Wu, X., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci165028 · Cited by 39
Self-citationDrug persistence – From antibiotics to cancer therapies
Kochanowski, K., Morinishi, L. S., Altschuler, S. J., & Wu, L. F. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.03.003 · Cited by 39
Montemurro, L., Raieli, S., Angelucci, S., Bartolucci, D., Amadesi, C., Lampis, S., Scardovi, A. L., Venturelli, L., Nieddu, G., Cerisoli, L., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0008 · Cited by 39
O-GlcNAcylation of PFKFB3 is required for tumor cell proliferation under hypoxia
Lei, Y., Chen, T., Li, Y., Shang, M., Zhang, Y., Jin, Y., Yu, Q., Guo, F., & Wang, T. (2020) · Oncogenesis · doi:10.1038/s41389-020-0208-1 · Cited by 41
Wu, C., Liu, Y., Liu, W., Zou, T., Lu, S., Zhu, C., He, L., Chen, J., Fang, L., Zou, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202202642 · Cited by 39
Hujber, Z., Horváth, G., Petővári, G., Krencz, I., Dankó, T., Mészáros, K. V., Rajnai, H., Szoboszlai, N., Leenders, W. P. J., Jeney, A., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0946-5 · Cited by 38
Castelli, G., Pelosi, E., & Testa, U. (2019) · Cancers · doi:10.3390/cancers11020260 · Cited by 39
Metabolic Drivers in Hereditary Cancer Syndromes
Sciacovelli, M., Schmidt, C., Maher, E. R., & Frezza, C. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033612 · Cited by 39
Self-citationOncometabolites—A Link between Cancer Cells and Tumor Microenvironment
Baryła, M., Semeniuk-Wojtaś, A., Róg, L., Kraj, L., Małyszko, M., & Stec, R. (2022) · Biology · doi:10.3390/biology11020270 · Cited by 40
Metabolic Control of Gametophore Shoot Formation through Arginine in the Moss Physcomitrium patens
Kawade, K., Horiguchi, G., Hirose, Y., Oikawa, A., Hirai, M. Y., Saito, K., Fujita, T., & Tsukaya, H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108127 · Cited by 36
Pregnancy Reprograms Large-Conductance Ca 2+ -Activated K + Channel in Uterine Arteries
Hu, X., Dasgupta, C., Chen, M., Xiao, D., Huang, X., Han, L., Yang, S., Xu, Z., & Zhang, L. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09059 · Cited by 38
Çubuk, C., Hidalgo, M. R., Amadoz, A., Rian, K., Salavert, F., Pujana, M. Á., Mateo, F., Herranz, C., Carbonell‐Caballero, J., & Dopazo, J. (2019) · npj Systems Biology and Applications · doi:10.1038/s41540-019-0087-2 · Cited by 38
Bechard, M. E., Smalling, R., Hayashi, A., Zhong, Y., Word, A. E., Campbell, S. L., Tran, A. V., Weiss, V. L., Iacobuzio-Donahue, C., Wellen, K. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17839-5 · Cited by 33
Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?
McCann, C. K., & Kerr, E. M. (2021) · Cancers · doi:10.3390/cancers13133351 · Cited by 36
Li, J., Wang, T., Hou, X., Li, Y., Zhang, J., Bai, W., Qian, H., & Sun, Z. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02750-8 · Cited by 41
TCA cycle-derived oncometabolites in cancer and the immune microenvironment
Sarkar, S., Chang, C.-I., Jean, J., & Wu, M. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01186-y · Cited by 39
Fumarates target the metabolic-epigenetic interplay of brain-homing T cells in multiple sclerosis
Ntranos, A., Ntranos, V., Bonnefil, V., Liu, J., Kim‐Schulze, S., He, Y., Zhu, Y., Brandstadter, R., Watson, C. T., Sharp, A. J., et al. (2018) · Brain · doi:10.1093/brain/awy344 · Cited by 37
Mitochondrial metabolism and cancer metastasis
Yu, D., Liu, C., & Guo, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.42 · Cited by 34
Yu, S.-H., Kim, S., Kim, Y., Lee, S.-E., Park, J. H., Cho, G., Ha, J.-C., Jung, H., Lim, S.-M., Han, K., et al. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.3.083 · Cited by 38
Kim, Y. L., Lee, W., Chung, S. H., Yu, B. M., Lee, Y. C., & Hong, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121010 · Cited by 35
PAK4 Phosphorylates Fumarase and Blocks TGFβ-Induced Cell Growth Arrest in Lung Cancer Cells
Chen, T., Wang, T., Liang, W., Zhao, Q., Yu, Q., Ma, C., Zhuo, L., Guo, D. S., Zheng, K., Zhou, C., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2575 · Cited by 34
Nocquet, L., Juin, P. P., & Souazé, F. (2020) · Cancers · doi:10.3390/cancers12103017 · Cited by 34
Hamza, A., Sirohi, D., Smith, S. C., & Amin, M. B. (2021) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000321 · Cited by 35
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Wu, S., Pan, R., Lu, J., Wu, X., Xie, J., Tang, H., & Li, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.896927 · Cited by 34
Hu, X., Dasgupta, C., Xiao, J., Yang, S., & Zhang, L. (2018) · The Journal of Physiology · doi:10.1113/jp276058 · Cited by 33
Integration of transcriptional and metabolic control in macrophage activation
Natoli, G., Pileri, F., Gualdrini, F., & Ghisletti, S. (2021) · EMBO Reports · doi:10.15252/embr.202153251 · Cited by 33
Silva-Llanes, I., Shin, C. H., Jiménez-Villegas, J., Gorospe, M., & Lastres‐Becker, I. (2023) · Antioxidants · doi:10.3390/antiox12030641 · Cited by 33
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31
Role of the KEAP1-NRF2 Axis in Renal Cell Carcinoma
Clerici, S., & Boletta, A. (2020) · Cancers · doi:10.3390/cancers12113458 · Cited by 36
Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells
Gonçalves, E., Sciacovelli, M., Costa, A. S. H., Tran, M. G. B., Johnson, T. I., Machado, D., Frezza, C., & Sáez-Rodríguez, J. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.011 · Cited by 31
Self-citationImmunosurveillance encounters cancer metabolism
Chuang, Y., Tzeng, S., Ho, P., & Tsai, C. (2024) · EMBO Reports · doi:10.1038/s44319-023-00038-w · Cited by 33
Metabolism – A cornerstone of cancer initiation, progression, immune evasion and treatment response
Lunt, S. Y., & Fendt, S. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.12.006 · Cited by 30
Park, H., Ohshima, K., Nojima, S., Tahara, S., Kurashige, M., Hori, Y., Okuzaki, D., Wada, N., Ikeda, J., & Morii, E. (2018) · Laboratory Investigation · doi:10.1038/s41374-017-0017-0 · Cited by 30
Serum metabolomic profiles associated with postmenopausal hormone use
Stevens, V. L., Wang, Y., Carter, B. D., Gaudet, M. M., & Gapstur, S. M. (2018) · Metabolomics · doi:10.1007/s11306-018-1393-1 · Cited by 31
Aberrant mitochondrial function in ageing and cancer
Whitehall, J. C., & Greaves, L. C. (2019) · Biogerontology · doi:10.1007/s10522-019-09853-y · Cited by 34
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 33
Zyla, R. E., & Hodgson, A. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2021-207830 · Cited by 31
Guo, L.-J., Chen, S., Ou, L., Li, S., Ye, Z.-N., & Liu, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369090 · Cited by 34
Fumarate drives EMT in renal cancer
Sciacovelli, M., & Frezza, C. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.137 · Cited by 30
Self-citationDrusian, L., Nigro, E. A., Mannella, V., Pagliarini, R., Pema, M., Costa, A. S. H., Benigni, F., Larcher, A., Chiaravalli, M., Gaude, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.106 · Cited by 30
Self-citationTesta, U., Pelosi, E., & Castelli, G. (2020) · Medicines · doi:10.3390/medicines7080044 · Cited by 30
Liang, J., Sun, G., Pan, X., Zhang, M., Shen, P., Zhu, S., Zhao, J., Zheng, L., Zhao, J., Chen, Y., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01182-7 · Cited by 28
Wang, H., Cai, X., & Ma, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s260129 · Cited by 29
Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways
Meng, W., Palmer, J. D., Siedow, M. R., Haque, S. J., & Chakravarti, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042246 · Cited by 34
Muralidharan, S., Sahoo, S., Saha, A., Chandran, S., Majumdar, S. S., Mandal, S., Levine, H., & Jolly, M. K. (2022) · Biomolecules · doi:10.3390/biom12020297 · Cited by 27
Katopodi, T., Petanidis, S., Anestakis, D., Charalampidis, C., Chatziprodromidou, I. P., Floros, G., Eskitzis, P., Zarogoulidis, P., Koulouris, C., Sevva, C. D., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325360 · Cited by 28
Oncometabolites in cancer: from cancer cells to the tumor microenvironment
Chen, L., & Huang, M. (2024) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00096-7 · Cited by 28
Lameirinhas, A., Miranda‐Gonçalves, V., Henrique, R., & Jerónimo, C. (2019) · Genes · doi:10.3390/genes10040264 · Cited by 28
Fuhler, G. M., Eppinga, H., & Peppelenbosch, M. P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.12.001 · Cited by 27
Zhang, J., Ni, Z., Zhang, Y., Guo, Y., Zhai, R., Wang, M., Gong, Z., Wang, M., Zeng, F., Gu, Z., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0067 · Cited by 33
Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes
Gantner, B. N., Palma, F. R., Pandkar, M. R., Sakiyama, M. J., Arango, D., DeNicola, G. M., Gomes, A. P., & Bonini, M. G. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.08.005 · Cited by 29
Jehn, U., Bayraktar, S., Pollmann, S., Marck, V. V., Weide, T., Pavenstädt, H. J., Brand, E., & Lenders, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111339 · Cited by 26
Ren, J., Li, S., Wang, C., Hao, Y., Liu, Z., Ma, Y., Liu, G., & Dai, Y. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113135 · Cited by 26
Gao, Q., Cheng, B., Chen, C., Lei, C., Lin, X., Nie, D., Li, J., Huang, L., Li, X., Wang, K., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.995 · Cited by 26
Mitochondrial Deficiencies in the Predisposition to Paraganglioma
Lussey‐Lepoutre, C., Buffet, A., Gimenez‐Roqueplo, A., & Favier, J. (2017) · Metabolites · doi:10.3390/metabo7020017 · Cited by 28
Agaimy, A., Amin, M. B., Gill, A. J., Popp, B., Reis, A., Berney, D. M., Magi‐Galluzzi, C., Sibony, M., Smith, S. C., Suster, S. M., et al. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.04.004 · Cited by 26
Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes
Ghosh, N., Mahalanobish, S., & Sil, P. C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116326 · Cited by 26
Hujber, Z., Petővári, G., Szoboszlai, N., Dankó, T., Nagy, N., Kriston, C., Krencz, I., Paku, S., Ozohanics, O., Drahos, L., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0544-y · Cited by 26
Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy
Cuyàs, E., Verdura, S., Martín-Castillo, B., Alarcón, T., Lupu, R., Bosch‐Barrera, J., & Menéndez, J. A. (2020) · Cancers · doi:10.3390/cancers12071757 · Cited by 26
Zeng, T., Tang, Z., Liang, L., Suo, D., Li, L., Li, J., Yuan, Y., Guan, X., & Li, Y. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12826 · Cited by 25
Konstantakou, E. G., Velentzas, A. D., Anagnostopoulos, A. K., Litou, Z. I., Konstandi, O. A., Giannopoulou, A. F., Anastasiadou, E., Voutsinas, G. E., Tsangaris, G. T., & Stravopodis, D. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171512 · Cited by 26
Cancer metabolism in a snapshot: MRS(I)
Julià‐Sapé, M., Candiota, A. P., & Arús, C. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4054 · Cited by 25
Thomas, L. W., Esposito, C., Stephen, J. M., Costa, A. S. H., Frezza, C., Blacker, T. S., Szabadkai, G., & Ashcroft, M. A. (2019) · Cancer & Metabolism · doi:10.1186/s40170-019-0200-4 · Cited by 25
Self-citationJo, H. A., Hyeon, J. S., Yang, S. H., Jung, Y., Ha, H., Jeong, C. W., Kwak, C. H., Kim, Y., Lee, H., Lee, J. P., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.031 · Cited by 25
Fumarate integrates metabolism and immunity in diseases
Cheng, J., Xiao, Y., & Jiang, P. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.03.008 · Cited by 25
The fuel and engine: The roles of reprogrammed metabolism in metastasis of primary liver cancer
Zhu, W., Lü, M., Wang, X., Xu, Z., Gao, C., & Qin, L. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.016 · Cited by 25
Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
Pal, A. K., Sharma, P., Zia, A., Siwan, D., Nandave, D., Nandave, M., & Gautam, R. K. (2022) · Pathophysiology · doi:10.3390/pathophysiology29020017 · Cited by 23
Metabolic dependencies of metastasis-initiating cells in female breast cancer
Young, C. M., Beziaud, L., Dessen, P., Alonso, A. M., Santamaria‐Martínez, A., & Huelsken, J. (2023) · Nature Communications · doi:10.1038/s41467-023-42748-8 · Cited by 26
Ambrosini, G., Cordani, M., Zarrabi, A., Alcón-Rodríguez, S., Sainz, R. M., Velasco, G., González‐Menéndez, P., & Dando, I. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01462-0 · Cited by 25
Gao, L., Wang, K., Zhang, N., Li, J., Qin, X., & Wang, X. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00853 · Cited by 23
Wu, T., Liu, T., Xing, L., & Ji, G. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6400 · Cited by 23
Giallongo, S., Costa, F., Longhitano, L., Giallongo, C., Ferrigno, J., Tropea, E., Vicario, N., Volti, G. L., Parenti, R., Barbagallo, I. A., et al. (2023) · Metabolites · doi:10.3390/metabo13070880 · Cited by 22
Linke, F., Johnson, J. E. C., Kern, S., Bennett, C., Lourdusamy, A., Lea, D., Clifford, S. C., Merry, C. L. R., Stolnik, S., Alexander, M. R., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01496-4 · Cited by 25
Padinharayil, H., Rai, V., & George, A. (2023) · Cancers · doi:10.3390/cancers15041070 · Cited by 26
Shakartalla, S. B., Ashmawy, N. S., Semreen, M. H., Fayed, B. E., Shareef, Z. A., Jayakumar, M. N., Ibrahim, S. M., Rahmani, M., Hamdy, R., & Soliman, S. S. M. (2024) · Scientific Reports · doi:10.1038/s41598-023-50866-y · Cited by 22
Begum, H. M., Ta, H. P., Zhou, H., Ando, Y., Kang, D. S., Nemes, K., Mariano, C. F., Hao, J., Yu, M., & Shen, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-47593-8 · Cited by 22
Shen, Y., Chu, Q., Yin, X., He, Y., Bai, P., Wang, Y., Fang, W. J., Timko, M. P., Fan, L., & Jiang, W. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa031 · Cited by 21
Pellattiero, A., Quirin, C., Magrin, F., Sturlese, M., Fracasso, A., Biris, N., Herkenne, S., Cendron, L., Gavathiotis, E., Moro, S., et al. (2025) · Science Advances · doi:10.1126/sciadv.adx4562 · Cited by 22
Mechanical regulation of metabolism, epigenetics, and their interplay
Nam, H., Yu, G., Ahn, S. I., & Nam, S. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00059-1 · Cited by 25
Zhang, C., Li, L., Zhang, Y., & Zeng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.686556 · Cited by 20
Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
Hipólito, A., Martins, F., Mendes, C., Lopes‐Coelho, F., & Serpa, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.656851 · Cited by 21
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Mukerjee, N., Nag, S., Bhattacharya, B., Alexiou, A. T., Mirgh, D., Mukherjee, D., Adhikari, M. D., Anand, K., Muthusamy, R., Gorai, S., et al. (2024) · Clinical and Translational Discovery · doi:10.1002/ctd2.260 · Cited by 22
Metadata
- Authors
- Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., Rajeeve, V., Cardaci, S., Foster, S., Yun, H., Cutillas, P., Warren, A., Gnanapragasam, V., Gottlieb, E., Franze, K., Huntly, B., Maher, E. R., Maxwell, P. H., Saez-Rodriguez, J., & Frezza, C.
- Affiliations
- University of Cambridge (GB)
- European Bioinformatics Institute (GB)
- Queen Mary University of London (GB)
- Cancer Research UK Scotland Institute (GB)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Frezza, Christian
- ORCID
- Sciacovelli, Marco
- Gonçalves, Emanuel
- Johnson, Timothy Isaac
- Zecchini, Vincent Roberto
- Gaude, Edoardo
- Tran, Maxine Gia Binh
- Rajeeve, Vinothini
- Cardaci, Simone
- Yun, Haiyang
- Cutillas, Pedro
- Warren, Anne
- Gnanapragasam, Vincent
- Gottlieb, Eyal
- Franze, Kristian
- Huntly, Brian
- Maher, Eamonn Richard
- Maxwell, Patrick Henry
- Frezza, Christian
- Venue
- Nature
- Published
- 2016-08-31
- Volume
- 537
- Issue
- 7621
- Pages
- 544-547
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5136292
- OpenAlex
- W2513105811
- Cited by
- 584
- References
- 40
- Citations by year
- 2026: 56 · 2025: 49 · 2024: 61 · 2023: 54 · 2022: 64 · 2021: 60 · 2020: 56 · 2019: 59 · 2018: 55 · 2017: 55 · 2016: 14
- FWCI
- 25.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-10-19)
- Open access
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (096956/Z/11/Z)
- Cancer Research UK (18278)
- National Institute for Health and Care Research (NF-SI-0514-10122)
- Medical Research Council (MC_PC_12009, MR/M010392/1, MC_UU_12022/6)
- Cancer Research UK Cambridge Institute, University of Cambridge
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- fumarate, fumarate hydratase, epithelial-mesenchymal transition, oncometabolites, TCA cycle, DNA demethylation, histone demethylation, alpha-ketoglutarate-dependent dioxygenase, miR-200 family, miR-429, metastasis, renal cell carcinoma, hereditary leiomyomatosis and renal cell carcinoma, cell migration, epigenetic modifications
- MeSH terms
- Animals, Cell Movement, Cells, Cultured, Fumarate Hydratase, Fumarates, Humans, Kidney Neoplasms, Mesoderm, Transcription Factors, MicroRNAs, Epigenesis, Genetic, Mice, HEK293 Cells, Epithelial-Mesenchymal Transition, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
